Predictors of Airway Intervention in Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema

Otolaryngology - Head and Neck Surgery (United States)

Volumn 153, Issue 4, 2015, Pages 544-550

  Kieu, Monica Chau Q ^a,b   Bangiyev, John N ^a,b   Thottam, Prasad John ^a,b   Levy, Phillip D ^c,d  

^a DETROIT MEDICAL CENTER   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c DETROIT RECEIVING HOSPITAL   (United States)

^d WAYNE STATE UNIVERSITY   (United States)

Author keywords

allergic reaction; angioedema; angiotensin converting enzyme inhibitor; tracheostomy

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL;

ADULT; AIRWAY; ANGIONEUROTIC EDEMA; ARTICLE; DYSPHAGIA; DYSPHONIA; FACE EDEMA; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERSALIVATION; LARYNGOSCOPY; LENGTH OF STAY; LOW RISK PATIENT; LOWER LIP; MAJOR CLINICAL STUDY; MALE; ODYNOPHAGIA; OTOLARYNGOLOGIST; PHYSICAL EXAMINATION; PRURITUS; RESPIRATORY DISTRESS; RESPIRATORY TRACT INTUBATION; SOFT PALATE; SYMPTOMATOLOGY; TONGUE; TRACHEOSTOMY; UPPER LIP; VOCAL CORD; AFRICAN AMERICAN; ANGIOEDEMA; CHEMICALLY INDUCED; MIDDLE AGED; RESPIRATION CONTROL;

AFRICAN AMERICANS; AIRWAY MANAGEMENT; ANGIOEDEMA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; FEMALE; HUMANS; LARYNGOSCOPY; MALE; MIDDLE AGED; TRACHEOSTOMY;

EID: 84943175150     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599815588909     Document Type: Article

References (13)

1. Ishoo E, Shah UK, Grillone GA, et al. Predicting airway risk in angioedema: staging system based on presentation. Otolaryngol Head Neck Surg. 1999; 121: 263-268.
2. Cugno M, Nussberger J, Cicardi M, et al. Bradykinin and the pathophysiology of angioedema. Int Immunopharmacol. 2003; 3: 311-317.
3. Banerji A, Clark S, Blanda M, et al. Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department. Ann Allergy Asthma Immunol. 2008; 100: 327-332.
4. Al-Khudari S, Loochtan MJ, Perterson E, et al. Management of angiotensin-converting enzyme inhibitor-induced angioedema. Laryngoscope. 2011; 121: 2327-2324.
5. McCormick M, Folbe AJ, Lin HS, et al. Site involvement as a predictor of airway intervention in angioedema. Laryngoscope. 2011; 121: 262-266.
6. Grant NN, Deeb ZE, Chia SH,. Clinical experience with angiotensin-converting enzyme inhibitor-induced angioedema. Otolaryngol Head Neck Surg. 2007; 137: 931-935.
7. Kostis JB, Packer M, Black HR, et al. Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial. Am J Hypertens. 2004; 17: 103-111.
8. Miller DR, Oliveria SA, Berlowitz DR, et al. Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors. Hypertension. 2008; 51: 1624-1630.
9. Makani H, Messerli FH, Romero MD, et al. Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors. Am J Cardiology. 2012; 110: 383-391.
10. Chiu AG., Newkirk KA, Davidson BJ,. Angiotensin-converting enzyme inhibitor-induced angioedema: a multicenter review and an algorithm for airway management. Ann Otol Rhinol Laryngol. 2001; 110: 834-840.
11. Gainer JV, Nadeau JH, Ryder D, et al. Increased sensitivity to bradykinin among African Americans. J Allergy Clin Immunol. 1996; 98: 283-287.
12. Bas M, Greve J, Stelter K, et al. Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series. Ann Emerg Med. 2010; 56: 278-282.
13. Bas M, Greve J, Stelter K, et al. A randomized trial of icatabant in ACE-inhibitor-induced angioedema. N Engl J Med. 2015; 372: 418-425.